European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme.
| Image |  |
|---|---|
| Description | scientific article published in December 2003 |
| Author/s |
author: Martin J van den Bent Alba A. Brandes |
| Publication date | December 1, 2003 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |